[1] 潘大彬,汪旻晖,曹蘅. 糖尿病心肌病发病机制的研究进展[J].中国临床药理学与治疗学,2013,18(7):831-836. [2] CHIU A P,WAN A,RODRIGUES B. Cardiomyocyte-endothelial cell control of lipoprotein lipase[J]. Biochim Biophys Acta,2016,1861(10):1434-1441. [3] 汪晓霞,王婵媛,林颖慧,等.缬沙坦对糖尿病大鼠心肌保护作用以及氧化应激的影响[J].现代生物医学进展,2015,15(24):4627-4630. [4] JOSHI M,KOTHA S R,MALIREDDY S, et al.Conundrum of pathogenesis of diabetic cardiomyopathy:role of vascular endothelial dysfunction,reactive oxygen species,and mitochondria[J]. Mol Cell Biochem,2014, 386(1/2):233-249. [5] OGAWA S,MORI T,NAKO K,et al. Angiotensin Ⅱ type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy[J]. Hypertension,2006,47(4):699-705. [6] YERRA V G,KALVALA A K,KUMAR A.Is oliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy[J]. J Nutr Biochem,2017,47:41-52. [7] 李佳伟,郭志新.替米沙坦对2型糖尿病大鼠心肌NADPH氧化酶亚单位表达的影响[J].解放军医学杂志,2011,36(10):1037-1040. [8] 王瑶,张彦飞,贡济宇.五味子多糖质量浓度测定及生物活性研究[J].长春中医药大学学报,2013,29(4):733-734. [9] 蒋军辉,徐小娜,王辉,等.五味子抗氧化作用研究[J].海峡药学,2015,27(1):30-32. [10] 许文奇,李先伟,郝伟,等.红杉醇对2型糖尿病大鼠心肌NADPH氧化酶亚单位p22phox、P47phox及iNOS蛋白表达的影响[J].中国临床药理学与治疗学,2014,19(6):626-631. [11] 金海英,王萍.糖尿病患者血清VEGF、KIM-1、IL-6及NADPH浓度的变化及其意义[J].现代医学,2019,47(1):63-66. [12] HUYNH K,BERNARDO B C, MCMULLEN J R,et al.Diabetic cardiomyopathy:Mechanisms and new treatment strategies targeting antioxidant signaling pathways[J]. Pharmacol Ther,2014,142(3):375-415. [13] SUN X,CHEN R C,YANG Z H,et al.Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis[J]. Food Chem Toxicol, 2014, 63:221-232. [14] HUYNH K, KIRIAZIS H, DU X J, et al. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice[J].Free Radic Biol Med,2013,60:307-317. [15] BELAMBRI S A,ROLAS L,RAAD H,et al.NADPH oxidase activation in neutrophils:Role of the phosphorylation of its subunits[J]. Eur J Clin Invest,2018,48(Suppl 2):e12951. [16] KUMAR R,THOMAS C M,YONG Q C,et al.The intracrine renin-angiotensin system[J].Clin Sci,2012,123(5):273-284. [17] 陈祥攀,杨解人,李先伟,等.红杉醇对2型糖尿病大鼠肝病NADPH氧化酶亚单位p22phox和p47phox表达的影响[J].药学学报,2013,48(4):489-494. [18] 成扶雨,余琪琪,袁伟.NADPH氧化酶在糖尿病心血管并发症中的研究进展[J].实用医学杂志,2019,35(14):2342-2346. [19] 贾奇,邓健锟,冯振东,等.蝉花通过抑制肾小管NADPH氧化酶/氧化应激治疗糖尿病肾病的研究[J].中国中西医结合肾病杂志,2018,19(12):1043-1047. [20] 刘江月.梓醇抑制NADPH氧化酶保护2型糖尿病早期血管内皮功能[J].中国中药杂志,2014,39(15):2936-2941. [21] 李宜轩,陈建光,李凤,等.北五味子提取物对实验性肝纤维化大鼠肝损伤的保护作用[J].吉林大学学报(医学版),2014,40(2):285-288. [22] 杨江辉,孙成博,耿嘉男,等.五味子提取物对糖尿病大鼠肾脏组织中基质金属蛋白酶表达的影响及其肾脏保护作用[J].吉林大学学报(医学版), 2017, 43(3):512-517. [23] 黄妍,刘秀,陶薇,等.五味子化学成分及抗2型糖尿病活性研究进展[J].中草药,2019,50(7):1739-1744. |